We’re inventing a new class of medicines—one applicable to therapeutic targets that have been dreamed about, but always considered impossible to drug. Our work requires us to be visionaries, explorers and leaders.  

We are fiercely independent as a leader in defying the limitations of current therapeutic modalities with our helicon polypeptides, and interdependent as a team as we work collaboratively to shift drug discovery paradigms and provide patients with better treatment options.

We’re relentless in our mission and will not stop until every target is druggable. We are audaciously committed to reaching universal druggability and will settle for nothing less.

We’re All-In on solving some of the hardest scientific challenges and creating one of the most effective new classes of drugs in history.